WO2023053015 - BICYCLIC AMINE DERIVATIVES AS GABAA α5 RECEPTOR MODULATORS
National phase entry is expected:
Publication Number
WO/2023/053015
Publication Date
06.04.2023
International Application No.
PCT/IB2022/059214
International Filing Date
28.09.2022
Title **
[English]
BICYCLIC AMINE DERIVATIVES AS GABAA α5 RECEPTOR MODULATORS
[French]
DÉRIVÉS BICYCLIQUES D'AMINE SERVANT DE MODULATEURS DU RÉCEPTEUR GABAA α5
Applicants **
RICHTER GEDEON NYRT.
Gyömröi út 19-21.
1103 Budapest, HU
Inventors
SZABÓ, György
Jókai Mór utca 121.
2234 Maglód, HU
POTOR, Attila
Bajcsy Zsilinszky u. 5.
2721 Pilis, HU
ERDÉLYI, Péter
Gergely u. 104/A
1103 Budapest, HU
BATA, Imre
Frankel Leó út 7.
1027 Budapest, HU
TÚRÓS, György István
Diófa u. 19.
2014 Csobánka, HU
KAPUS, Gábor László
Napsugár u. 4.
2119 Pécel, HU
ÉLIÁS, Olivér
Tóth Ágoston utca 18.
8700 Marcali, HU
Priority Data
P2100338
29.09.2021
HU
Application details
| Total Number of Claims/PCT | * |
| Number of Independent Claims | * |
| Number of Priorities | * |
| Number of Multi-Dependent Claims | * |
| Number of Drawings | * |
| Pages for Publication | * |
| Number of Pages with Drawings | * |
| Pages of Specification | * |
| * | |
| * | |
International Searching Authority |
EPO
* |
| Applicant's Legal Status |
Legal Entity
* |
| * | |
| * | |
| * | |
| * | |
| Entry into National Phase under |
Chapter I
* |
| Translation |
|
Recalculate
* The data is based on automatic recognition. Please verify and amend if necessary.
** IP-Coster compiles data from publicly available sources. If this data includes your personal information, you can contact us to request its removal.
Quotation for National Phase entry
| Country | Stages | Total | |
|---|---|---|---|
| China | Filing | 2753 | |
| EPO | Filing, Examination | 24379 | |
| Japan | Filing | 614 | |
| South Korea | Filing | 576 | |
| USA | Filing, Examination | 37310 |
Total: 65632 USD
The term for entry into the National Phase has expired. This quotation is for informational purposes only
Abstract[English]
α5 receptor, process for the preparation and intermediates of the preparation process thereof, pharmaceutical compositions comprising them alone or in combination with one or more other active ingredients and their use as medicaments.[French]
α5, un procédé pour leur préparation et des intermédiaires pour le procédé de préparation de ceux-ci, des compositions pharmaceutiques les comprenant seuls ou en combinaison avec un ou plusieurs autres principes actifs et leur utilisation en tant que médicaments.